Healthcare organisations are facing the simultaneous pressures of demonstrating ROI on AI investments, addressing clinician ...

This year's Nobel Prize in Physiology or Medicine has been awarded to three scientists for their work on regulatory T-cells ...

Kronos was bought out earlier this year for a knockdown price of around $35 million by serial biotech acquisition specialist ...

Last year, Idorsia Pharma claimed FDA approval for Tryvio (aprocitentan) as the first endothelin receptor antagonist for ...

Radiopharmaceuticals have rapidly evolved from a specialised therapeutic niche into a cornerstone of modern oncology. By ...

While advances in drug development have accelerated dramatically in recent years, pharmaceutical manufacturing processes have ...

Roche's entry into the category with afimkibart (RG6631) stemmed from its purchase of Telavant for $7.1 billion, and since then it has advanced the drug into a phase 3 programme, also in inflammatory ...

Trump called for the MMR vaccine – a pillar of childhood immunisation that protects against measles, mumps, and rubella (whooping cough) – to be broken up into three shots given separately in a Truth ...

Scotland was held up as proof that new models of adoption, AI-enabled diagnostics, and genomics can transform care at pace.

Privosegtor is Oculis ' second ophthalmic drug to start a pivotal trials programme after OCS-01, a topical anti-TNF drug in ...

The algorithm will be added to Roche's navify library of clinical decision-making algorithms and other digital health ...

Speculation is building that President Donald Trump may delay the introduction of his 100% tariff rate on pharmaceutical imports in order to negotiate more deals with drugmakers on drug pricing. The ...